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Background: Hemodialysis access by autogenous arteriovenous fistulas (AVFs) is generally recommended due to lower
mortality, morbidity, and cost vs graft and catheter use. Many dialysis patients lack the common superficial veins used for
standard AVF options and require transposition of a deep vein for autogenous dialysis access through a long open incision
(open/AVF-T). These operations may require prolonged time for healing, thus extending catheter-based dialysis. We
report our experience with minimally invasive techniques for creating AVF-Ts using an endoscopic procedure (endo/
AVF-T).
Methods: We reviewed our vascular access database of consecutive access operations to identify consecutive patients with
endo/AVF-Ts. For comparison, we also reviewed the immediate preceding traditional open/AVF-T operations that we
previously reported. We evaluated demographics, time to access use, and primary, assisted, and cumulative patency.
Results: We identified 100 consecutive endo/AVF-T operations attempted, and 98 were technically successful. The
analysis excluded two conversions to successful open/AVF-T. The mean age of the 98 patients in the endo/AVF-T study
group was 60 years (range, 22-94 years), 59 (60.2%) were women, 48 (49.0%) were diabetic, 20 (20.4%) were obese, and
52 (53.1%) had had previous access surgery. Mean time to initial use of the access for endo/AVF-Ts was 6 weeks for
primary and 12 weeks for staged transpositions. Mean follow-up was 14 months (range, 1-30 months). The 12- and
24-month cumulative patencies were 95.5% and 88.6%. The 78 traditional open/AVF-T operations from our previous
report were reviewed for comparison. The mean age was 62 years (range, 18-83 years), 57 (73.1%) were women, 44
(56.4%) were diabetic, 15 (19.2%) were obese, and 46 (59.0%) had previous access surgery. Mean time to initial use of the
access for open/AVF-Ts was 8 weeks for primary and 16 weeks for staged operations. Mean follow-up was 18 months
(range, 3-48 months). The 12- and 24-month cumulative patencies were 96.0 and 88.9%. No grafts were used in any
patient during the study period.
Conclusion: Time to access use was less with endoscopic AVF-T (P < .01) for both primary and staged operations.
Primary, assisted, and cumulative patency rates were the same for open and technically successful endoscopic transposi-
tions. Endoscopic AVF-Ts offer a viable alternative to open AVF-Ts. (J Vasc Surg 2010;51:1451-6.)There is expert consensus that an arteriovenous fistula
(AVF) is the preferred vascular access for hemodialysis, with
lower mortality, morbidity, and cost compared with graft
or catheter access.1-6 Many hemodialysis patients lack the
common superficial veins used for standard AVF options.
Creating an autogenous access in these individuals often
involves transposition (AVF-T) of a deep or inaccessible
vein, most often the basilic vein, through an open incision
(open/AVF-T) along the medial aspect of the arm or
forearm, or both. These long incisions may require pro-
longed time for healing, delaying use of the new access for
dialysis. We report our experience with minimally invasive
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METHODS
This study was approved by our Institutional Review
Board. Patients with endo/AVF-Ts were identified from
our vascular access database of consecutive access opera-
tions. We also reviewed the immediately preceding tradi-
tional open/AVF-Ts that we previously reported and com-
pared the two groups.7 We evaluated demographics, time
to access use, and primary, assisted, and cumulative (sec-
ondary) patency. Our previous report included all vascular
access transposition operations performed from May 2003
to September 2006, before our first use of endoscopic
procedures for basilic vein AVF-T.7 This study compared
the consecutive technically successful endo/AVF-Ts con-
structed from September 2006 throughMarch 2009. Early
during the study period, two operations were converted to
successful open/AVF-T for technical reasons and were not
included in the endo/AVF-T study group. All operations
were performed by the communicating author (W.C.J) at a
university-affiliated tertiary medical center.
Patients had ultrasound (US) mapping in addition to
physical examination by the operating surgeon during the
initial office consultation.8 All major upper extremity veins
and arteries were examined in each patient with the intent
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simple direct AVF was not feasible for the patients in this
study; however, a patent basilic vein was identified with a
minimum diameter of 2.5 mm. When the basilic vein was
2.5 to 4.0 mm in diameter, the access was created in staged
operations. US imaging was used again briefly in the oper-
ating suite to mark the outflow vein, venous branches, and
arterial inflow options while confirming the preoperative
assessment and plan.
Patients were followed up postoperatively in the surgi-
cal clinic with physical andUS examinations until the access
was in use. We generally expected access vein maturation
diameter to be6 mm and access flow volume to be400
mm/min after 4 weeks. If there was a question of AVF
functionality, a fistulogram was obtained with intervention
at that time, if needed. If the clinical assessment suggested
that the access would soon mature, then a brief period of 2
to 4 weeks of observation with reassessment was used. We
recommended establishing same-site “buttonhole” cannu-
lation for our patients, when possible.
Primary patency was defined as the time in months with
uninterrupted patency and without intervention. Primary
assisted patency was the time of uninterrupted patency
from the original AVF construction, where any interven-
tional procedure was necessary. Cumulative (secondary)
patency was the period from the original AVF construction
regardless of interventions or thrombosis until abandon-
ment of the access or until the study period was comple-
ted.9 Patency in this report refers to functional access
cannulation in the dialysis unit with two needles and the
prescribed dialysis flow of the many nephrologists and
dialysis units in our vascular access referral practice.10
Patency rates for staged transpositions and primary
transpositions were analyzed as a single group for this study
and the previous open AVF-T report. Patient selection
criteria did not change during the two study periods. In
each group, veins that were 4 mm by US examination
were completed as staged operations. Individuals with bra-
chial and cephalic vein access operations were not included
in this study. No grafts were used for dialysis access in any
patient during the study periods.
Statistical analysis. Prism 4 software (GraphPad Soft-
ware, La Jolla, Calif) was used in data analysis. Significance
of differences was determined at P  .05.
Technique. Our technique for endo/AVF-T has var-
ied with increasing experience. The Terumo VirtuoSaph
endoscopic vein harvesting system (TerumoCardiovascular
Systems Corp, Ann Arbor, Mich) has become our preferred
device for the safe endoscopic mobilization of the basilic vein,
while securely sealing and dividing most side branches (Fig 1,
A). We previously used a small probe passed through the vein
for retraction; however, the Terumo device retracts and posi-
tions the vein to expose side branches for division (Fig 1, B).
Rarely, a large side branch requires use of the EnSeal cautery
device (Ethicon Endo-Surgery, Cincinnati, Ohio) developed
for laparoscopic use.
US is a critical tool in the preoperative evaluation of
patients for vascular access procedures.3 We use preopera-tive US imaging to map the pathway of the basilic vein,
locate side branches, and allow for better planning of
incisions (Fig 2,A). We believe that US imaging performed
by the operating surgeon offers even more benefits in
selecting the best site and procedure for AVF creation.8
Low-pressure carbon dioxide insufflation is important in
keeping open the narrow subcutaneous working tunnel.
Harvesting basilic veins endoscopically was greatly en-
hanced by the availability of specific devices developed for
saphenous vein harvest. With specific vein harvesting in-
struments, the learning curve is relatively brief. Instruc-
tional videos may be available from the manufacturers.
As in all AVF-Ts, care must be taken to ensure that the
new transposed vein path is located anteriorly and superfi-
cially enough to ensure ease of access and avoid inadvertent
cannulation of the brachial artery (Fig 2, B). The vein
should be positioned in the subcutaneous tissue within 3 to
6 mm of the skin surface but not adherent to the dermis.
Advancing the cut and 
coagulate component to 
engage a side branch.
Basilic vein retracted in 
vein keeper device.
B
A
Fig 1. A, An endoscopic vein harvesting device is used for basilic
vein arteriovenous fistula transposition. B, Endoscopic view shows
the basilic vein within the retracting holder of the vein harvesting
device.Before tunneling, the vein is carefully inspected for leaks
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use the proximal radial artery for inflow, when possible,
minimizing the risk of steal syndrome.11 When the brachial
artery is used for inflow, we limit size of the anastomosis to
less than three-quarters of the diameter of the brachial
artery. AVF procedures in this study were constructed
using local anesthetic and sedation, with a regional block by
the surgeon using the open axillary incision, infiltrating the
medial antebrachial and other cutaneous nerves.
Hill et al12 reported that a basilic vein diameter4 mm
predicted a higher success rate for transpositions, and we
continue to use two-stage access operations for transposi-
tions when the basilic vein is 4 mm in diameter.7,13 Our
endoscopic dissection technique of the basilic vein after a
previous first-stage AVF is the same as that for a primary
endoscopic transposition. The first stage anastomosis is left
undisturbed, and the mature basilic vein is divided before
tunneling. The small incision for endoscopic dissection and
vein division is usually located just proximal to the cubital
Vein Branches
Brachial Artery
Original basilic
vein position
Transposed 
vein position
A
B
Fig 2. A, The surgeon uses a brief preoperative ultrasound study
to map vessels. B, Postoperative photo shows primary endoscopic
basilic vein transposition. In some patients, a single incision al-
lowed exposure of the brachial artery and the distal basilic vein.fossa and overlying the juncture with the forearm and upperarm basilic veins, allowing creation of a wide flair for the
end-to-end anastomosis.
RESULTS
Of the 100 consecutive endo/AVF-T operations at-
tempted, 98 were technically successful and form the study
group in this report. Two operations were converted to
successful open/AVF-T for technical reasons early during
the study period before our use of specific vein harvesting
devices and were not included in this study. The 98 tech-
nically successful endo/AVF-T operations were compared
with our previous report of 78 open/AVF-Ts.7 The demo-
graphic features were generally similar between the two
groups (Table I); however, the number of staged transpo-
sitions was proportionately larger in the open/AVF-T co-
hort. The mean follow-up time was 4 months longer in the
open/AVF-T patient group, and the mean age was slightly
less. When they were initially evaluated, 88 patients in the
endo/AVF-T study group had started dialysis. Among the
52 patients who had had previous access surgery were 26
with at least one AV graft and 18 with multiple failed AV
grafts. The presence of previous AV grafts did not generally
affect endo/AVF-T operations, although one slender pa-
tient required excision of a graft segment before the newly
Table I. Demographic comparison of patients with
endoscopic (endo/AVF-T) and open arteriovenous fistula
transpositions (open/AVF-T)
Variables Endo/AVF-T Open/AVF-T
Transpositions, No. 98 78
Age, mean (range) y 60 (22-94) 62 (18-83)
Female gender, No. (%) 59 (60.2) 57 (73.1)
Obese, No. (%) 20 (20.4) 15 (19.2)
Diabetic, No. (%) 48 (49.0) 44 (56.4)
Previous access surgery, No. (%) 52 (53.1) 46 (59.0)
Staged operations, No. (%) 36 (36.8) 58 (74.3)
Follow-up, mean (range) mo 14 (1-30) 18 (3-48)
Table II. Outcome comparison of patients with
endoscopic (endo) and open arteriovenous fistula
transpositions (AVF-T)
Outcome Endo/AVF-T Open/AVF-T P
Transpositions, No. 98 78
Weeks to use, mean (range)
Primary transposition 6 (2-10) 8 (6-20) .01
Staged transposition 12 (8-12) 16 (10-36) .01
Primary patency, % .08
12 mo 58.4 45.7
24 mo 31.8 27.6
Assisted patency, % .08
12 mo 89.3 93.5
24 mo 78.7 85.5
Cumulative patency, % .51
12 mo 95.5 96.0
24 mo 88.6 88.9transposed vein was tunneled.
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data are reported in Table II. Patency rates did not signifi-
cantly differ between the two groups; however, initial ac-
cess utilization was sooner for both primary and staged
endo/AVF-Ts (P  .01). Fig 3 shows patency curves for
endo/AVF-Ts in this study. As in our previous report of
open/AVF-Ts, patency did not differ between primary and
staged operations in this study of endo/AVF-Ts.
Eighteen patients died during the study period, none
related to the endo/AVF-T surgical procedure. Five pa-
tients were censored with a functioning access during the
study period, and three of these individuals were lost to
follow-up at 8, 13, and 25 months. One patient with a
functional access changed to peritoneal dialysis, and one
received a kidney transplant. One individual with a func-
tional endo/AVF-T required urgent surgical exploration
for an expanding hematoma and bleeding after cannulation
difficulties with loss of the fistula. Inflow was through the
proximal radial artery in 25 patients, the ulnar artery in 2,
and the brachial artery in the remaining 71. Patency was not
affected by brachial artery inflow vs a radial or ulnar artery
anastomosis.
No aneurysms developed and no patients required
treatment for steal syndrome during the study period.Most
interventions were by fistulogram with angioplasty. Six
patients required surgical revisions. Two proximal radial
artery anastomoses were revised to brachial artery inflow,
one before a second-stage transposition. Two individuals
had brachial inflow revisions, and two patients underwent
venous outflow revision. Only one patient with a staged
transposition required an angioplasty before the second
operation. A later staged transposition was completed in all
of the first-stage AVF patients.
Five patients were identified during this endo/AVF-T
study period who had open instead of endoscopic opera-
tions. As noted previously, two patients with marginal veins
underwent conversion to successful open operations due to
difficult endoscopic dissections early in the series and be-
fore our use of specific vein harvesting devices. The neces-
Fig 3. Kaplan-Meier curve is shown for cumulative, assisted, and
primary patency after endoscopic arteriovenous fistula transposi-
tion. The dotted lines indicate when patient numbers fell below
10% and the curve becomes imprecise.sary endoscopic equipment was not available for anotherpatient. In two other individuals with staged operations,
US imaging identified multiple large, short, side branches
that required direct suture ligation with open procedures.
These five individuals, who were not included in the anal-
ysis, had successful open/AVF-Ts, and their fistulas re-
mained functional during the study period.
DISCUSSION
Endoscopic harvest of the saphenous vein for cardiac
surgery was described in 1997 by Jordan et al,14 and later
by other authors.15-19 This technique was rapidly embraced
by the surgical community and was soon used for extremity
arterial bypass procedures.20-22 Several studies noted that
endoscopic saphenous vein harvest decreased patient dis-
comfort, lowered the incidence of wound complications,
and shortened hospital stays.18,23-26 Gazoni et al20 found
the patency of endoscopically harvested saphenous vein
grafts was the same as the patency with standard open
harvest techniques and that the grafts demonstrated equiv-
alency in long-term success.
Since the first reported basilic vein transposition for
dialysis access by Dagher et al27 in 1976, long incisions
have been used tomobilize the basilic vein for AVF-Ts. The
first endo/AVF-T for vascular access was reported by Mar-
tinez et al28 in 2001 and later described by other surgeons,
including Hayakawa et al,29 Tordoir et al,30 and others.31
Various techniques and devices for vein harvest are avail-
able, such as Terumo, SaphLITE (Teleflex Medical, Re-
search Triangle Park, NC ), Ethicon, and even common
laryngoscopes.32-36 As in the reports of endoscopic saphe-
nous vein harvest for cardiac and arterial bypass surgery, we
believe that endo/AVF-T decreases scarring, discomfort,
and inflammation.
Surgeons and nephrologists in the United States have
generally waited longer to allow AVF cannulation than
physicians in other countries. Although the Dialysis Out-
comes and Practice Pattern Study (DOPPS) found cannu-
lation 2 weeks of AVF construction increased the risk of
access failure, cannulation 2 weeks did not change fistula
outcomes.37,38 We found endoscopic transposition proce-
dures have allowed prompt use of these AVFs due, in our
opinion, to decreased wound edema and discomfort. We
did not measure these variables, but subjectively observed
less edema and inflammation in these extremities and be-
lieve it may be responsible for the significantly shorter time
to initial AVF cannulation reported in this study.
We anticipate AVFs will be successfully accessed within
4 to 6 weeks using our general criteria for a matured vein
diameter of 6 mm and access flow volume to be at least
400 mm/min. This expectation of timely maturation and
prompt intervention is reflected in the primary patency
rates in this and our previous report. We do not view
interventional procedures as a marker of surgical failure
but, when indicated, as a key component of maturation and
maintenance for successful AVFs.
We do not use endoscopic transposition procedures for
brachial or cephalic vein access operations. We construct
brachial vein transpositions with open operations (generally
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veins, in addition to tortuosity of the brachial vein and
proximity to the artery and nerve.39Difficulty with access of
a cephalic vein AVF is due to obesity, not vessel location.
For these patients, we prefer a lipectomy procedure to
transposition, leaving the vein undisturbed.40 Liposuction
may become a more common operation for these individ-
uals in the future.41 We did not include operative times in
our analysis because our techniques and available tools
changed significantly during the study period. We believe
our current surgical time for an endo/AVF-T is often
shorter than for open/AVF-Ts.
Central access catheters were common in the patients in
this report. Our general practice has been to obtain central
venograms for individuals with extensive catheter usage, a
history of arm swelling, or clinical findings of central venous
stenosis or occlusion. Confirmation of central venous ste-
nosis does not preclude our recommending creation of an
AVF. If arm edema develops, then a central venogram and
angioplasty effectively resolves the problem for most pa-
tients. Even in patients with central venous occlusion, if
extensive collaterals are present, we often proceed with
AVF construction when other access options are not favor-
able. We are retrieving these data for patients with central
venous stenosis or occlusion, or both, and hope to report
our findings in the future.
Limitations to this study include the retrospective de-
sign and the review of a single surgeon’s outcomes. The
groups had similar demographics; however, the endo/
AVF-T study excluded five patients whose operations were
performed with the standard open technique for technical
reasons. All patients in both groups were evaluated postop-
eratively by the same experienced surgeon using US imag-
ing and clinical judgment before the initial access cannula-
tion. This adds the potential for unrecognized bias in the
timing of the cannulation; however, we believe this was not
a factor in the findings of this study. More staged proce-
dures were used in the open/AVF-T group than in the
endo/AVF-T group. The same indications and criteria
were applied, including minimal vein size, for staged oper-
ations in both groups. We are not able to explain this
observed difference. The vein harvesting devices are single-
use items and add significant cost to the procedure.
CONCLUSION
Time to access use was less with endo/AVF-T (P 
.01) for both primary and staged operations. Primary,
assisted, and cumulative patency rates were the same for
open and technically successful endoscopic transpositions.
Endo/AVF-Ts offer a viable alternative to open/AVF-Ts.
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